Phathom Pharmaceuticals has a 52 week low of $5.21 and a 52 week high of $19.71. The firm has a market capitalization of $394.55 million, a PE ratio of -1.01 and a beta of 0.54. Insider Activity ...
FLORHAM PARK, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for ...
Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...
Gastroesophageal Reflux disease market Insights. DelveInsight's Gastroesophageal Reflux Disease Market report offers an in-depth understanding of the epide ...
After hours: February 18 at 5:33:57 PM EST Loading Chart for FULC ...
After hours: 7:11:37 p.m. EST ...
After hours: 7:58:23 p.m. EST ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback